Nissay Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,820
Closed -$576K 765
2022
Q1
$576K Buy
7,820
+266
+4% +$23.7K 0.01% 684
2021
Q4
$1.08M Sell
7,554
-545
-7% -$93.6K 0.01% 631
2021
Q3
$1.68M Buy
8,099
+242
+3% +$53.3K 0.01% 501
2021
Q2
$1.67M Buy
+7,857
New +$1.44M 0.01% 504

Other funds holding NVAX

Nissay Asset Management's NVAX Position: Q2 2022 in Review

Nissay Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 7,820 shares — an estimated $576K sold.

Nissay Asset Management first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $1.68M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Nissay Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Nissay Asset Management sold 7,820 Novavax shares in Q2 2022, an estimated $576K.
  • Nissay Asset Management first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • Nissay Asset Management's Novavax position peaked at $1.68M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Nissay Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.